BRTX vs MCD · rev $401.0K vs P/E 23, rev $25.92B
BioRestorative Therapies Inc (BRTX) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
BRTX currently screens at market cap $10.2M. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the BRTX and MCD stock pages for the full models.
Not investment advice.